FDA approves ‘potential blockbuster’ migraine jab from Lundbeck
Axovant misreports trial results, Lundbeck Alzheimer’s drug fails
Ulf Wiinberg becomes acting CEO
New study with 23andMe and Milken Institute looks to determine causes of depression.
Collaboration will initially focus on Parkinson’s disease and schizophrenia.